AltPlus Holdings Inc.
Supplementary Explanation Materials on Fundraising
Announced a fundraising scheme aimed at financing development of new titles and related purposes. Issuance of 23,000,000 new shares and allocation of the 13th–15th series of new share subscription rights, raising a total of approximately 887 million yen. Payment date is 2026-12-25. Maximum dilution rate is approximately 299.87%, but final net increase is curtailed by partial cancellation of rights. Uses of funds include development and operation of new titles, M&A financing, and repayment of bonds. Subject to amendment of the articles of incorporation and approval by the general shareholders meeting.
Key Figures
- Allocation of 23,000,000 shares
- 13th & 14th series new share subscription rights total 295,500,000 shares
- Fundraising amount 240 million yen (13th) + 114 million yen (14th) + 69 million yen (new shares) = approx. 887 million yen
- Dilution rate 299.87% (of which new shares 23.34%, 13th series 156.78%, 14th series 38.56%, 15th series 81.18%)
AI要約
Overview and Purpose of Fundraising
These supplementary explanatory materials detail a fundraising scheme that includes issuance of new shares through third-party allotment, issuance of the 13th to 15th series of new share subscription rights, issuance of private placement bonds, purchase agreements, and amendments to the articles of incorporation. The purpose is to secure funds for development and operation of new titles, funds for M&A, and allocation to repayment of existing bonds. Specific conditions such as payment dates, allottee, exercise periods, and projected dilution rates are clearly stated, assuming approval at the general shareholders meeting.
Use of Proceeds and Measures to Ensure Financial Stability
Uses of proceeds are expected to total approximately 874 million yen for (1) development and operation of new titles, (2) M&A funds (Okazaki Holdings), (3) M&A funds (others), and (4) repayment of existing bonds. The structure secures funds via issuance of the 13th and 14th series of new share subscription rights, third-party allotment, and issuance of bonds to EVO FUND. Although the maximum dilution rate is high at 299.87%, the materials explain that acquisition and cancellation of remaining rights will reduce the number of potential shares. If approval at the general shareholders meeting is not obtained, the measures will not be implemented.
AltPlus Holdings Inc.
Company overview · Stock price · Financial data · All IR
